Maple Grove, Minnesota-based Entellus Medical, which has developed minimally invasive treatments for chronic sinusitis, announced Wednesday that it has raised $35 million in its fifth round of financing. The round was led by new investor Covidien Ventures, a venture capital firm that invests in companies developing new innovative medical devices, diagnostics and pharmaceuticals. Aside from […]
Entellus Medical Inc., which is developing a less-invasive therapy to treat chronic sinusitis, has hired a new chief executive. Brian Farley, who has served on the company’s board since 2008 and previously led VNUS Medical Technologies Inc., takes over the CEO job from Entellus co-founder Tom Ressemann, according to a company statement. Ressemann will stay […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Quantity or quality? Like most things in life, that’s not always an either/or question. Most people would prefer both. But as the University of Minnesota starts to shop its intellectual property a little more aggressively to investors, as evidenced by its first Life Sciences Showcase event at University Enterprise Laboratories Thursday morning, it’s something to […]
Midwest health care start-ups attracted $780 million in investments in 2009, according to the BioEnterprise Midwest Health Care Venture Investment Report. While the number of companies winning investments last year -- 156 -- was about the same as in 2008, the dollar volume of the investments dropped 26 percent.
The development is an important milestone for the company as it endeavors to convince more insurers to cover its FinESS sinus treatment in an office setting.
The company will use the funding to expand its sales and customer support teams, and prepare to launch its sinus-treatment system in Europe.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.